Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer. - Test2 - elhamkhani - TriplyDB

Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.

Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.

http://www.wikidata.org/entity/Q34086557

about

Is pathology necessary to predict mortality among men with prostate-cancer?PSA Velocity and Doubling Time in Diagnosis and Prognosis of Prostate Cancer.Using the weighted area under the net benefit curve for decision curve analysis Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.Stopping screening, when and how?Moonshot Objectives: Catalyze New Scientific Breakthroughs-Proteogenomics Prostate-Specific Antigen Trends Predict the Probability of Prostate Cancer in a Very Large U.S. Veterans Affairs Cohort

P2860

Q34769040-1F5CF3E3-0ECD-41DE-9D4C-0322397DAA44 Q36033729-24345DE7-85B0-44B4-9BD6-088BD26951E0 Q36081053-B70200A6-7813-4C5D-A3C5-7A8407DF64CE Q40139232-9A53BB8E-45FC-4FFA-AB80-68FBFEFADBED Q52624226-20D49143-9D67-43AE-9865-A8D1E78DCA27 Q58426910-6B01DE11-67B5-47BD-ABD0-CFECDAD5BDCC Q58799069-D1A5F8DF-ED66-470C-8756-B05FC3C28403

P2860

Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.

http://www.wikidata.org/entity/Q34086557

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Interpretation of the prostate ...... e-threatening prostate cancer.

@ast

Interpretation of the prostate ...... e-threatening prostate cancer.

@en

Interpretation of the prostate ...... e-threatening prostate cancer.

@nl

type

label

Interpretation of the prostate ...... e-threatening prostate cancer.

@ast

Interpretation of the prostate ...... e-threatening prostate cancer.

@en

Interpretation of the prostate ...... e-threatening prostate cancer.

@nl

prefLabel

Interpretation of the prostate ...... e-threatening prostate cancer.

@ast

Interpretation of the prostate ...... e-threatening prostate cancer.

@en

Interpretation of the prostate ...... e-threatening prostate cancer.

@nl

P1433

Q34086557-B69E2CDD-0D5D-4A82-91A8-29DEB8095188

P1476

Q34086557-6CFEE947-0293-4679-A6A3-EBD50ECEAB51

P2093

Q34086557-6F0843A9-4597-4CD2-BC0A-042587881151

Q34086557-A9A31A8B-4627-4AE2-891E-8C1932E82FCD

Q34086557-C378FDC5-6AB1-42F7-A63A-998E300AB149

Q34086557-CA039540-8089-43C4-B226-166417E4A3A6

Q34086557-D827498A-1C42-4BC7-BE2D-ACD70E9A0399

P2860

Q34086557-125A13C2-0557-4BAF-A9D2-8C354C0E575E

Q34086557-19A47D7A-EC11-44AC-A1E2-F30AA786F38E

Q34086557-29CD22D7-4672-4A4B-B2D2-0F98B978A435

Q34086557-2AD045EE-412A-4E84-A3B1-AA81B5465E2D

Q34086557-315F2C0F-7C36-484D-8AFC-6FDD658CA150

Q34086557-43164B56-36B5-404A-90DF-DD91449CC05E

Q34086557-511D66E1-694E-477C-991F-DD1E3F94DB8A

Q34086557-61260B26-B4B1-4AA8-BDDF-28E35D869962

Q34086557-66292733-D390-4930-A037-1969321B1F4E

Q34086557-7DF518F5-2630-4276-9256-2ECD0CB77BDD

P304

Q34086557-1CEECF90-6B3C-4A11-AB35-D9704190548C

P31

Q34086557-0C62C1AE-C856-4B4D-8605-6C4AC2FEF822

P356

Q34086557-B00F6613-1FC8-4250-AEA3-41BE77932E8A

P433

Q34086557-BAC72625-BFFA-4981-803B-C9E267D7B2D9

P478

Q34086557-3AC04F46-37A9-4417-93E8-94CED0221B48

P50

Q34086557-F7659C6C-2D02-40D0-AA4C-045F633D7529

P577

Q34086557-19D0C605-6782-4F42-A3A4-9ACF0F229F98

P698

Q34086557-96E70FAB-5728-4FC7-B56F-31102CA65C65

P932

Q34086557-30642149-609A-4E95-A337-B6FD698BB6D4

P356

J.1464-410X.2010.09363.X

P1433

BJU International

P1476

Interpretation of the prostate ...... e-threatening prostate cancer.

@en

P2093

Anna E Kettermann

http://www.w3.org/2001/XMLSchema#string

Bruce J Trock

http://www.w3.org/2001/XMLSchema#string

E Jeffrey Metter

http://www.w3.org/2001/XMLSchema#string

H Ballentine Carter

http://www.w3.org/2001/XMLSchema#string

Luigi Ferrucci

http://www.w3.org/2001/XMLSchema#string

P2860

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy.

Prostate specific antigen testing among the elderly--when to stop?

Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era.

Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence.

Detection of life-threatening prostate cancer with prostate-specific antigen velocity during a window of curability.

Systematic review of pretreatment prostate-specific antigen velocity and doubling time as predictors for prostate cancer.

Pretreatment prostate-specific antigen (PSA) velocity and doubling time are associated with outcome but neither improves prediction of outcome beyond pretreatment PSA alone in patients treated with radical prostatectomy

P304

1284-90; discussion 1290-2

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1464-410X.2010.09363.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20477823

http://www.w3.org/2001/XMLSchema#string

P932

2928882

http://www.w3.org/2001/XMLSchema#string